| Genomic Medicine |
1 |
1 |
| Cancer |
0 |
0.99 |
| Liquid Biopsy |
0 |
0.73 |
| Cancer Risk |
0 |
0.71 |
| Biologic Therapy |
0 |
0.7 |
| Renal Cell Carcinoma |
0 |
0.7 |
| Kidney Cancer |
0 |
0.69 |
| Pancreatic Cancer |
0 |
0.69 |
| Gastrointestinal Cancer |
0 |
0.68 |
| Primary Care |
0 |
0.16 |
| Revenue and Practice Management |
0 |
0.98 |
| Genetics |
0 |
0.12 |
| Genetic Testing |
0 |
0.1 |
| Tumor |
0 |
0.1 |
| Breast |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Health Care Reform |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Lung |
0 |
0.08 |
| Bile Duct Tumor |
0 |
0.07 |
| Blood |
0 |
0.06 |
| Health Insurance |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Preventive Screening |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.04 |
| Indiana |
0 |
0.04 |
| Leukemia |
0 |
0.04 |
| Medical Oncology |
0 |
0.04 |
| Prostate |
0 |
0.04 |
| Biliary Tract |
0 |
0.03 |
| NHS |
0 |
0.03 |
| Waldenstrom Macroglobulinemia |
0 |
0.03 |
| Anxiety |
0 |
0.02 |
| Anxiety Disorder |
0 |
0.02 |
| Bile |
0 |
0.02 |
| Biopsy |
0 |
0.02 |
| Bone |
0 |
0.02 |
| Burns |
0 |
0.02 |
| Europe |
0 |
0.02 |
| Grant |
0 |
0.02 |
| Informed Consent |
0 |
0.02 |
| Kentucky |
0 |
0.02 |
| Kidney |
0 |
0.02 |
| Liver |
0 |
0.02 |
| Lymphoma |
0 |
0.02 |
| Medical Education |
0 |
0.02 |
| Medicare |
0 |
0.02 |
| New York |
0 |
0.02 |
| Obesity |
0 |
0.02 |
| Ohio |
0 |
0.02 |
| Outpatient Clinic |
0 |
0.02 |
| Ovary |
0 |
0.02 |
| Pancreas |
0 |
0.02 |
| Plasma |
0 |
0.02 |
| Precision Medicine |
0 |
0.02 |
| Small Intestine |
0 |
0.02 |
| Smoking |
0 |
0.02 |
| Tissue |
0 |
0.02 |
| Tobacco Cessation |
0 |
0.02 |
| UK Site Content |
0 |
0.02 |
| Uterus |
0 |
0.02 |
| Wound Management |
0 |
0.02 |